Open the map

Waters CorporationWAT

Life science tools · NYSE · USA

$429.13
Down 1.6% todayClose

Up 14.8% this year and +14.6% since June 26, ahead of the life science sector at +10.7%. Waters Corporation supplies 2 mapped companies.

This year
+14.8%
1 year
+37.0%
P/E
250.7
P/S
9.0
P/B
2.7

Price vs the life science sector

since Jun 26WATLife science sector, equal weight
Waters Corporation (WAT) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. WAT: +14.6% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+10%+20%Jun 26AugSepOct 8WAT +14.6%Sector +10.7% Waters Corporation (WAT) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. WAT: +14.6% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+10%+20%Jun 26AugSepOct 8WAT+14.6%Sector+10.7%

Supply chain

2 customers
SUPPLIERS →→ CUSTOMERSNone mappedEli Lilly (LLY)LLYEli Lilly−1.6%AbbVie (ABBV)ABBVAbbVie+0.4%WATWaters Corporat… Open the full chain →

About Waters Corporation

Waters sells liquid chromatography and mass spectrometry systems; pharmaceutical companies and other laboratories buy them along with the consumables and software that keep them running.

Theme exposure

Analytical instrumentsChromatographyMass spectrometry

Products

  • Liquid chromatography (LC)
  • Mass spectrometry
  • Consumables & software

Competitors

Risks

  • Pharma capex cycle
  • China exposure

Same segment: Life science tools

Instruments, reagents and equipment for research, development and production. Segment 5 of 8 in the Medicine, pharma & life science value chain.

Compare WAT

Side by side with the largest companies in the same segment.

See where Waters Corporation sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.

Open the Life science value chain →